Brian Eric Bayley

Brian Eric Bayley discloses dealings in NervGen Pharma Corp. to SEDI. In total, 8 filings cover trades dated from 20 May 2020 to 4 September 2026.

The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

On 8 September 2026 came the latest disclosure, an option exercise in NervGen Pharma Corp. Typically, a trade is published a median of 2 days after it takes place. Until a filing is published, the market cannot know about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.